MarketCapTrends
ACRS
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare

Aclaris Therapeutics, Inc. Cash on Hand 2017–2025

Aclaris Therapeutics, Inc. annual/quarterly cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Aclaris Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 20.0M, a 18.76% decrease year-over-year.
  • Aclaris Therapeutics, Inc. cash on hand for 2025 were 20.0M, a 18.76% decrease from 2024.
  • Aclaris Therapeutics, Inc. cash on hand for 2024 were 24.6M, a 38.39% decrease from 2023.
  • Aclaris Therapeutics, Inc. cash on hand for 2023 were 39.9M, a 11.92% decrease from 2022.
  • Aclaris Therapeutics, Inc. cash on hand for 2022 were 45.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Aclaris Therapeutics, Inc. Annual Cash on Hand (Millions of US $)
2025$20
2024$25
2023$40
2022$45
2021$27
2020$22
2019$34
2018$168
2017$20
Aclaris Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$20
2024-12-31$25
2023-12-31$40
2022-12-31$45
2021-12-31$27
2020-12-31$22
2019-12-31$34
2018-12-31$168
2017-12-31$20

Aclaris Therapeutics, Inc. Cash on Hand — FAQ

Aclaris Therapeutics, Inc. (ACRS) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ACRS's cash on hand history?

The chart and table above show Aclaris Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.